DaxibotulinumtoxinA-lanm (DAXXIFYTM) is FDA Approved! Daxxify (known also as Daxi) is the first and only neuromodulator with an FDA approved duration of six months. The clinical trials were conducted here in our office, and it has been so rewarding to be involved in the early stages of this product. During the trial, I found some participants were satisfied with results as long as nine months - that's a game changer for aesthetic medicine. For patients who are in the office twice yearly for dermal fillers, Daxxify will add convenience by eliminating the need for additional neuromodulator visits. DAXXIFYTM is the first and only neuromodulator stabilized with Peptide Exchange TechnologyTM (PXT) and is free of both human serum albumin and animal-based components. I look forward to adding this to my arsenal against aging, and welcoming it into the office soon! . . . #daxxify #daxi #revance #aestheticsolutions